The Explorers: A Passion for Science Leads to New Territory
April 6, 2023
After decades of working in industry and academia, biophysicists Alex Savtchenko and Elena Molokanova still have big dreams.
Your search for “CIRM” returned 65 results
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
September 16, 2014
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
Anti-Leukemia Drug May Also Work Against Ovarian Cancer
November 17, 2014
An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well, report researchers at the University of California, San Diego School of Medicine.
Protein-Protein Interaction Activates and Fuels Leukemia Cell Growth
December 21, 2015
Building upon previous research, scientists at University of California, San Diego School of Medicine and UC San Diego Moores Cancer report that a protein called Wnt5a acts on a pair of tumor-surface proteins, called ROR1 and ROR2, to accelerate the proliferation and spread of chronic lymphocytic leukemia (CLL) cells, the…
UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License
May 2, 2016
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
